MarkChristopherBenyunesMD
Oncology • South San Francisco, CABiotechnology at Genentech, Inc. Sr. Group Medical Director Genentech
Dr. Benyunes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 DNA Way
Mailstop 444B
South San Francisco, CA 94080Phone+1 650-225-1628
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1989 - 1992
Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1987- Johns Hopkins UniversityInternship, Internal Medicine, 1984 - 1985
Duke University School of MedicineClass of 1984
Certifications & Licensure
WA State Medical License 1989 - 2023
NC State Medical License 1987 - 1990
GA State Medical License 1989 - 1989
SC State Medical License 1989 - 1989
AL State Medical License 1988 - 1988
IA State Medical License 1988 - 1988
WV State Medical License 1988 - 1988- American Board of Internal Medicine Internal Medicine
- Join now to see all
Publications & Presentations
PubMed
- 1339 citationsPertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast CancerSandra M. Swain, José Baselga, Sung-Bae Kim, Jungsil Ro, Vladimir Semiglazov
The New England Journal of Medicine. 2015-02-18 - 1726 citationsPertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast CancerJosé Baselga, Javier Cortes, Sung-Bae Kim, Seock-Ah Im, Roberto Hegg
The New England Journal of Medicine. 2012-01-11 - 860 citationsAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast CancerGunter von Minckwitz, Marion Procter, Evandro de Azambuja, Dimitrios Zardavas, Mark C. Benyunes
The New England Journal of Medicine. 2017-06-05
Authored Content
- Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast CancerJuly 2017
Grant Support
- Immunotherapy After Bone Marrow TransplantationNational Cancer Institute1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
